ADAM SMITH: Open Payments
NPI 1932604451 · LEITCHFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 38 payments from 11 companies in 2025. Trend: 2023 $558 · 2024 $638 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $213 |
| ABBVIE INC. | 15 | $149 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
| Lundbeck LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Indivior Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: FANAPT, VRAYLAR, Auvelity, ABILIFY MAINTENA, SPRAVATO, AUSTEDO XR, SUBLOCADE, LYBALVI.
Industry payments across KY — which companies pay providers there.
